Patent application number | Description | Published |
20140114950 | FORMULATING GLOBAL STATISTICS FOR DISTRIBUTED DATABASES - The present invention extends to methods, systems, and computer program products for formulating global statistics for parallel databases. In general, embodiments of the invention merge (combine) information in multiple compute node level histograms to create a global histogram for a table that is distributed across a number of compute nodes. Merging can include aligning histogram step boundaries across the compute node histograms. Merging can include aggregating histogram step-level information, such as, for example, equality rows and average range rows (or alternately equality rows, range rows, and distinct range rows), across the compute node histograms into a single global step. Merging can account for distinct values that do not appear at one or more compute nodes as well as distinct values that are counted at multiple compute nodes. A resulting global histogram can be coalesced to reduce the step count. | 04-24-2014 |
20140114952 | OPTIMIZING QUERIES OF PARALLEL DATABASES - The present invention extends to methods, systems, and computer program products for optimizing queries of parallel databases. Queries can be partially optimized at an optimizer that is unaware of its use to optimize queries for parallel processing. The optimizer can produce a data structure (e.g., a SQL Server MEMO) that encapsulates a logical serial plan search space. The logical serial plan search space may not incorporate any notion of parallelism into the plan space itself. A parallel-aware optimizer can parallelize the logical serial plan search space by augmenting the data structure (e.g., transforming the SQL Server MEMO into a parallel MEMO). Augmentation can be with data movement operations that move data associated one or more compute nodes in a distributed architecture. Cost estimates can be calculated for the operations contained in the parallelized data structure. The parallel plan with the lowest estimated cost can be selected for the query. | 04-24-2014 |
20140137237 | SINGLE SYSTEM IMAGE VIA SHELL DATABASE - A single system image is provided for a parallel data warehouse system by exposing a shell database within a database management system comprising metadata and statistics regarding externally stored data. Further, functionality of the database management system can be exploited to perform pre-execution tasks. In one instance, one or more execution plans can be generated by the database management system for an input command and subsequently employed to generate a distributed execution plan. | 05-15-2014 |
20150347508 | PARTIAL RESULT CLASSIFICATION - A query can be executed over incomplete data and produce a partial result. Moreover, the partial result or portion thereof can be classified in accordance with a partial result taxonomy. In accordance with one aspect, the taxonomy can be defined in terms of data correctness and cardinality properties. Further, partial result analysis can be performed at various degrees of granularity. Classified partial result can be presented on a display device to allow user to view and optionally interact with the partial result. | 12-03-2015 |
Patent application number | Description | Published |
20090202632 | Sublingual Buccal Effervescent - A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administerable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of additional pH adjusting substance in combination with the effervescent for promoting the absorption of drugs is also disclosed. | 08-13-2009 |
20090304790 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 12-10-2009 |
20110212034 | Sublingual Buccal Effervescent - A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed. | 09-01-2011 |
20110223115 | SUBLINGUAL BUCCAL EFFERVESCENT - A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed. | 09-15-2011 |
20130315993 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The invention features a kit. The kit includes: (i) a first unit dosage form consisting essentially of about 120 mg of dimethylfumarate and one or more pharmaceutically acceptable excipients, wherein the dimethylfumarate is formulated for delayed release; and (ii) a second unit dosage form consisting essentially of about 240 mg of dimethylfumarate and one or more pharmaceutically acceptable excipients, wherein the dimethylfumarate is formulated for delayed release. | 11-28-2013 |
20130316003 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The invention features a method of treating a subject in need of treatment for multiple sclerosis. The method involves orally administering to the subject in need thereof a pharmaceutical composition in unit dosage form consisting essentially of (a) from about 120 mg to about 240 mg of dimethylfumarate formulated for delayed release, and (b) one or more pharmaceutically acceptable excipients, wherein following the orally administering of the unit dosage form monomethylfumarate appears in the plasma of the subject upon hydrolysis of dimethylfumarate and the Cmax of the monomethylfumarate in the plasma of the subject is between about 0.4 and about 2 mg/L, and wherein about 480 mg of dimethylfumarate per day is orally administered to the subject. | 11-28-2013 |
20140037720 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The invention relates to a method of treating a subject in need of treatment for multiple sclerosis including orally administering to the subject in need thereof a delayed release pharmaceutical composition using an increasing dose regimen, wherein an initial daily amount of drug administered is increased later to a higher daily amount and the pharmaceutical composition consists essentially of (a) dimethylfumarate and (b) one or more pharmaceutically acceptable excipients. | 02-06-2014 |
20140037740 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The invention features a delayed release composition wherein the active ingredient consists essentially of about 240 mg of dimethylfumarate and one or more pharmaceutically acceptable excipients. | 02-06-2014 |
20140099364 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 04-10-2014 |
20140193495 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 07-10-2014 |
20140199386 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 07-17-2014 |
20140199387 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 07-17-2014 |
20140199388 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 07-17-2014 |
20140199390 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 07-17-2014 |
20140199392 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 07-17-2014 |
20140199393 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 07-17-2014 |
20140200272 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 07-17-2014 |
20140200273 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 07-17-2014 |
20140205659 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects. | 07-24-2014 |
20150024049 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER - The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side effects. | 01-22-2015 |
Patent application number | Description | Published |
20130320741 | READY TO ASSEMBLE FURNITURE SYSTEM - A component interface assembly for attaching the individual subcomponents of an RTA furniture system. Each component interface assembly having an elongated alignment slot cut into one of the subcomponents of the RTA furniture kit and a retention element affixed to a second corresponding subcomponent such that the first and second subcomponents can be secured together by inserting the retention element into the alignment slot. The alignment slot is positioned on the first subcomponent such that positioning the retention element for insertion into the slot aligns the second subcomponent with the first subcomponent providing tool-less alignment and engagement of the subcomponents. The assembled components may have cutouts on confronting planar surfaces of the respective first and second subcomponents providing enhanced storage for shipping the RTA furniture components. | 12-05-2013 |
20140091601 | REVERSE DRIVE ASSEMBLY FOR RECLINER POWER MECHANISM - A reverse drive assembly for recliner in which a motor is mounted at the end of the horizontal track, proximate to the rear of the recliner. A traveler assembly having a reverse transfer linkage having a greater bend is positioned along the track forward of the motor, wherein the traveler assembly actuates extension of an ottoman assembly and the reclining of a seat back. | 04-03-2014 |
20140091606 | POWER MECHANISM FOR RECLINERS - A power mechanism for a recliner having a limiter controlling the relative angle between a transfer linkage and arm affixed to the drive axle as the transfer linkage applies tangential force to the arm to rotate the drive axle. The limiter prevents the relative angle between the transfer linkage from over collapsing to minimize strain on the linkage assembly and the motor driving the rotation of the drive axle. | 04-03-2014 |
20150305504 | DROP IN SEAT DECK FOR FURNITURE ASSEMBLIES - A drop-in seat deck for furniture assemblies. Various embodiments reduce the complexity and bulk of the seating frame, and also reduce the labor associated with assembly. Unlike the conventional spring suspensions, which apply constant spring loaded forces on the frame rails to maintain the springs in tension, the spring load force of the disclosed drop-in seat deck is provided by solely by the structure of the drop-in seat deck. Thus, the frame can be designed to support only the weight of the seated person is transferred to the rails of the seating frame, without consideration for pre-loading the seat deck. In various embodiments, dimensional changes to the seat deck occur under load. In some embodiments, these changes are accommodated by enabling a free end of the seat deck to slide on a support surface; in other embodiments, the changes are accommodated by flexures that are integral to the seat deck. | 10-29-2015 |
Patent application number | Description | Published |
20120128124 | WALK-THROUGH IMAGING SYSTEM HAVING VERTICAL LINEAR X-RAY SOURCE - A system and method for acquiring x-ray imaging data from a subject is disclosed. The x-ray imaging system includes a first support structure oriented in a vertical fashion and a second support structure oriented in a vertical fashion and spaced apart from the first support structure to define a scanning area configured to receive a subject to be scanned. A linear x-ray source is affixed to the first support structure on one side of the scanning area and is oriented in a vertical fashion, with the linear x-ray source configured to emit x-rays towards the subject. A linear detector arrangement is affixed to the second support structure on another side of the scanning area and is generally opposite the linear x-ray source. The linear detector arrangement is configured to receive x-rays after passing through the subject. | 05-24-2012 |
20120130145 | SYSTEM AND METHOD FOR PERFORMING A COMPREHENSIVE HEALTH ASSESSMENT - A system and method for providing a comprehensive overall health assessment is disclosed. A health assessment system includes first and second support structures oriented in a vertical fashion and spaced apart from one another to define a scanning area configured to receive a subject to be scanned, an x-ray imaging system incorporated into the first and second support structures and configured to acquire x-ray image data from the subject in a standing position, and at least one additional data acquisition device configured to acquire health related data from the subject. The health assessment system also includes a computer programmed to receive the x-ray image data and the health related data and generate a diagnostic output based on the x-ray image data and the health related data, the diagnostic output comprising at least one of a health related diagnosis and a recommendation for future action. | 05-24-2012 |
20120291784 | METHOD AND SYSTEM FOR VISUALIZING MECHANICAL VENTILATION INFORMATION - Methods and systems for visualizing mechanical ventilation information are provided. One system includes a user interface for a medical system having a ventilator is provided. The user interface includes a memory storing one or more sensor measurements for a patient and a processor. The processor is programmed to display a visualization of a tidal volume determined from one of the sensor measurements of the patient and display a visualization of lung compliance for the patient, wherein the tidal volume visualization and the lung compliance visualization are displayed concurrently. | 11-22-2012 |
20130032147 | METHOD AND SYSTEM FOR VISUALIZING MECHANICAL VENTILATION INFORMATION - A medical system having a ventilator is provided. The medical system includes a memory storing data related to patient and ventilator parameters. A processor is programmed to organize, in time, the data related to the patient and ventilator parameters. A viewer displays the patient and ventilator parameters for an overall monitoring time period on a timeline. A reference marker is displayed on the timeline to select a segment of the patient and ventilator parameters corresponding to a past monitoring time, wherein the segment selected represents a time segment within the overall monitoring time period. The patient and ventilator parameters corresponding to the time segment are displayed. | 02-07-2013 |
20130032149 | METHOD AND SYSTEM FOR VISUALIZING MECHANICAL VENTILATION INFORMATION - A medical system having a ventilator is provided. The medical system includes a memory for storing one or more patient and ventilation parameters. A processor is programmed to organize the one or more patient parameters into at least one of past patient and ventilation parameters, present patient and ventilation parameters, or future patient and ventilation parameters. A viewer displays at least one of the past patient or ventilation parameters, the present patient or ventilation parameters, or the future patient or ventilation parameters. The past patient and ventilation parameters, the present patient and ventilation parameters, and the future patient and ventilation parameters are selectable on the viewer. | 02-07-2013 |
20130176230 | SYSTEMS AND METHODS FOR WIRELESSLY CONTROLLING MEDICAL DEVICES - Systems and methods for wirelessly controlling medical devices are provided. One system includes a portable user interface having a housing and a communication module within the housing configured to wirelessly communicate with at least one medical device. The portable user interface also includes a display displaying a graphical user interface to control the at least one medical device remotely, wherein the displayed graphical user interface corresponds to a control interface of the at least one medical device. | 07-11-2013 |
20130235080 | METHOD AND SYSTEM FOR DISPLAYING INFORMATION ON LIFE SUPPORT SYSTEMS - Methods and systems for displaying information on life support systems (LSS) are provided. One LSS includes a patient monitoring portion configured to acquire, as LSS information, patient measurement information from a monitored patient. The LSS also includes a communication device configured to communicate with a remote device to obtain, as non-LSS information, information acquired by the remote device. The LSS further includes a display configured to display a user interface that presents the non-LSS information. | 09-12-2013 |
20130238314 | METHODS AND SYSTEMS FOR PROVIDING AUDITORY MESSAGES FOR MEDICAL DEVICES - Methods and systems for providing auditory messages for medical devices are provided. One method includes receiving semantic rating scale data corresponding to a plurality of sounds and medical message descriptions and performing semantic mapping using the received semantic rating scale data. The method also includes determining profiles for audible medical messages based on the semantic mapping and generating audible medical messages based on the determined profiles. | 09-12-2013 |
20140111335 | METHODS AND SYSTEMS FOR PROVIDING AUDITORY MESSAGES FOR MEDICAL DEVICES - Methods and systems for providing auditory messages for medical devices are provided. One system includes at least one medical device configured to generate a plurality of medical messages and a processor in the at least one medical device configured to generate an auditory signal corresponding to one of the plurality of medical messages. The auditory signal is configured based on a functional relationship linking psychological sound perceptions in a clinical environment to acoustic and musical sound variables. | 04-24-2014 |